Status:
COMPLETED
Endometrial Malignancy in Breast Cancer Patients With or Without AUB
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Endometrial Neoplasms
Eligibility:
FEMALE
43-70 years
Brief Summary
In order to assess the hysteroscopic, histopathologic, and ultrasonographic aspects of uterine monitoring in postmenopausal breast cancer patients with or without abnormal uterine bleeding (AUB), as w...
Detailed Description
20-25% of postmenopausal women undergoing tamoxifen (TAM) therapy develop polyps, according to recent studies. Many large (\>2 cm) and molecularly changed uterine polyps are usually seen in these wome...
Eligibility Criteria
Inclusion
- In case of AUB: ultrasonographic endometrial thickness \>5 mm at transvaginal ultrasound
- In case of non-AUB group ultrasonographic suspicion of endometrial or myometrial abnormalities
Exclusion
- severe comorbidities (cardiovascular, metabolic, endocrine, and immunological disorders)
- receiving any other form of pharmacologic therapy
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
283 Patients enrolled
Trial Details
Trial ID
NCT05977829
Start Date
January 1 2020
End Date
July 30 2022
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cagliari
Cagliari, Italy